US Stock MarketDetailed Quotes

TLSA Tiziana Life Sciences

Watchlist

0.9190
+0.1091+13.47%

Close May 28 16:00 ET

94.74MMarket Cap-5405P/E (TTM)

Tiziana Life Sciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

(FY)Dec 31, 2020

(FY)Dec 31, 2019

(FY)Dec 31, 2018

(FY)Dec 31, 2017

(FY)Dec 31, 2016

(FY)Dec 31, 2015

(FY)Dec 31, 2014

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

19.97%-15.7M

9.87%-19.62M

-91.99%-21.76M

-66.79%-11.34M

-47.67%-6.8M

-4.6M

Net income from continuing operations

-11.98%-17.24M

42.24%-15.4M

5.93%-26.66M

-183.04%-28.34M

-1.35%-10.01M

5.96%-9.88M

-6.21%-10.51M

22.66%-9.89M

-130.15%-12.79M

---5.56M

Operating gains losses

149.74%1.52M

-58.48%-3.05M

20.57%-1.93M

-1,127.97%-2.43M

179.73%236K

---296K

----

Depreciation and amortization

88.24%96K

-63.83%51K

54.95%141K

-64.03%91K

1,481.25%253K

--16K

----

Other non cash items

---625K

----

-93.92%866K

9,087.74%14.24M

76.14%155K

633.33%88K

0.00%12K

--12K

----

--1.32M

Change In working capital

-35.91%-1.58M

-50.58%-1.16M

-162.03%-773K

-203.51%-295K

-85.33%285K

-17.60%1.94M

82.08%2.36M

1,071.24%1.3M

-142.83%-133.34K

--311.29K

-Change in receivables

-31.61%-1.52M

-1,215.91%-1.16M

81.20%-88K

-265.63%-468K

---128K

--0

-55.37%54K

153.38%121K

-60.03%-226.67K

---141.64K

-Change in payables and accrued expense

--0

-97.81%-1.36M

-495.95%-685K

-60.32%173K

202.78%436K

--144K

----

-Change in other current assets

-92.02%80K

94.19%1M

--516K

----

---180K

----

-Change in other current liabilities

-139.77%-138K

167.25%347K

---516K

----

-101.16%-23K

--1.98M

----

Cash from discontinued investing activities

Operating cash flow

19.97%-15.7M

9.87%-19.62M

-91.99%-21.76M

-66.79%-11.34M

-47.67%-6.8M

38.91%-4.6M

-8.76%-7.53M

15.15%-6.93M

-140.69%-8.16M

---3.39M

Investing cash flow

Cash flow from continuing investing activities

68.64%-1.25M

-3,173.85%-4M

205.69%130K

-2,975.00%-123K

-4K

Net PPE purchase and sale

--0

-633.33%-22K

25.00%-3K

---4K

--0

97.92%-1K

---48K

--0

----

Net business purchase and sale

----

--99.61K

Net investment purchase and sale

68.64%-1.25M

---4M

--0

---120K

--0

----

---294K

----

Net other investing changes

----

--152K

----

Cash from discontinued investing activities

Investing cash flow

68.64%-1.25M

-3,173.85%-4M

205.69%130K

-2,975.00%-123K

---4K

--0

99.71%-1K

---342K

--0

--99.61K

Financing cash flow

Cash flow from continuing financing activities

172.73%40K

-139.13%-55K

-100.03%-23K

4,384.88%75.35M

-83.35%1.68M

10.09M

Net issuance payments of debt

-116.36%-119K

63.82%-55K

-33.33%-152K

-106.79%-114K

--1.68M

--0

-93.66%961K

296.99%15.16M

--3.82M

Net common stock issuance

--24K

--0

--71.16M

--0

554.41%10.09M

151.14%1.54M

-84.29%614K

25.30%3.91M

--3.12M

Proceeds from stock option exercised by employees

--135K

--0

-97.00%129K

--4.3M

--0

--1.51M

----

Cash from discontinued financing activities

Financing cash flow

172.73%40K

-139.13%-55K

-100.03%-23K

4,384.88%75.35M

-83.35%1.68M

554.41%10.09M

-2.10%1.54M

-91.25%1.58M

163.91%18M

--6.82M

Net cash flow

Beginning cash position

-57.04%18.12M

-35.91%42.19M

32,812.00%65.82M

-96.23%200K

8,187.50%5.3M

-98.90%64K

-55.80%5.8M

291.05%13.13M

--3.36M

--0

Current changes in cash

28.54%-16.91M

-9.29%-23.67M

-133.90%-21.66M

1,347.81%63.89M

-193.28%-5.12M

191.61%5.49M

-5.25%-5.99M

-157.90%-5.69M

178.79%9.83M

--3.53M

Effect of exchange rate changes

92.96%-28K

79.93%-398K

-214.23%-1.98M

10,750.00%1.74M

106.43%16K

-198.03%-249K

115.55%254K

---1.63M

----

End cash Position

-93.47%1.18M

-57.04%18.12M

-35.91%42.19M

32,812.00%65.82M

-96.23%200K

8,187.50%5.3M

-98.90%64K

-56.01%5.8M

273.97%13.19M

--3.53M

Free cash flow

19.97%-15.7M

9.96%-19.62M

-92.13%-21.78M

-66.74%-11.34M

-47.76%-6.8M

38.92%-4.6M

-8.03%-7.53M

14.57%-6.97M

-140.69%-8.16M

---3.39M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021	(FY)Dec 31, 2020	(FY)Dec 31, 2019	(FY)Dec 31, 2018	(FY)Dec 31, 2017	(FY)Dec 31, 2016	(FY)Dec 31, 2015	(FY)Dec 31, 2014
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	19.97%-15.7M	9.87%-19.62M	-91.99%-21.76M	-66.79%-11.34M	-47.67%-6.8M	-4.6M
Net income from continuing operations	-11.98%-17.24M	42.24%-15.4M	5.93%-26.66M	-183.04%-28.34M	-1.35%-10.01M	5.96%-9.88M	-6.21%-10.51M	22.66%-9.89M	-130.15%-12.79M	---5.56M
Operating gains losses	149.74%1.52M	-58.48%-3.05M	20.57%-1.93M	-1,127.97%-2.43M	179.73%236K	---296K	----	----	----	----
Depreciation and amortization	88.24%96K	-63.83%51K	54.95%141K	-64.03%91K	1,481.25%253K	--16K	----	----	----	----
Other non cash items	---625K	----	-93.92%866K	9,087.74%14.24M	76.14%155K	633.33%88K	0.00%12K	--12K	----	--1.32M
Change In working capital	-35.91%-1.58M	-50.58%-1.16M	-162.03%-773K	-203.51%-295K	-85.33%285K	-17.60%1.94M	82.08%2.36M	1,071.24%1.3M	-142.83%-133.34K	--311.29K
-Change in receivables	-31.61%-1.52M	-1,215.91%-1.16M	81.20%-88K	-265.63%-468K	---128K	--0	-55.37%54K	153.38%121K	-60.03%-226.67K	---141.64K
-Change in payables and accrued expense	--0	-97.81%-1.36M	-495.95%-685K	-60.32%173K	202.78%436K	--144K	----	----	----	----
-Change in other current assets	-92.02%80K	94.19%1M	--516K	----	----	---180K	----	----	----	----
-Change in other current liabilities	-139.77%-138K	167.25%347K	---516K	----	-101.16%-23K	--1.98M	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	19.97%-15.7M	9.87%-19.62M	-91.99%-21.76M	-66.79%-11.34M	-47.67%-6.8M	38.91%-4.6M	-8.76%-7.53M	15.15%-6.93M	-140.69%-8.16M	---3.39M
Investing cash flow
Cash flow from continuing investing activities	68.64%-1.25M	-3,173.85%-4M	205.69%130K	-2,975.00%-123K	-4K	0
Net PPE purchase and sale	--0	--0	-633.33%-22K	25.00%-3K	---4K	--0	97.92%-1K	---48K	--0	----
Net business purchase and sale	----	----	----	----	----	----	----	----	----	--99.61K
Net investment purchase and sale	68.64%-1.25M	---4M	--0	---120K	--0	--0	----	---294K	----	----
Net other investing changes	----	----	--152K	----	----	----	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	68.64%-1.25M	-3,173.85%-4M	205.69%130K	-2,975.00%-123K	---4K	--0	99.71%-1K	---342K	--0	--99.61K
Financing cash flow
Cash flow from continuing financing activities	172.73%40K	-139.13%-55K	-100.03%-23K	4,384.88%75.35M	-83.35%1.68M	10.09M
Net issuance payments of debt	-116.36%-119K	63.82%-55K	-33.33%-152K	-106.79%-114K	--1.68M	--0	--0	-93.66%961K	296.99%15.16M	--3.82M
Net common stock issuance	--24K	--0	--0	--71.16M	--0	554.41%10.09M	151.14%1.54M	-84.29%614K	25.30%3.91M	--3.12M
Proceeds from stock option exercised by employees	--135K	--0	-97.00%129K	--4.3M	--0	--1.51M	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	172.73%40K	-139.13%-55K	-100.03%-23K	4,384.88%75.35M	-83.35%1.68M	554.41%10.09M	-2.10%1.54M	-91.25%1.58M	163.91%18M	--6.82M
Net cash flow
Beginning cash position	-57.04%18.12M	-35.91%42.19M	32,812.00%65.82M	-96.23%200K	8,187.50%5.3M	-98.90%64K	-55.80%5.8M	291.05%13.13M	--3.36M	--0
Current changes in cash	28.54%-16.91M	-9.29%-23.67M	-133.90%-21.66M	1,347.81%63.89M	-193.28%-5.12M	191.61%5.49M	-5.25%-5.99M	-157.90%-5.69M	178.79%9.83M	--3.53M
Effect of exchange rate changes	92.96%-28K	79.93%-398K	-214.23%-1.98M	10,750.00%1.74M	106.43%16K	-198.03%-249K	115.55%254K	---1.63M	----	----
End cash Position	-93.47%1.18M	-57.04%18.12M	-35.91%42.19M	32,812.00%65.82M	-96.23%200K	8,187.50%5.3M	-98.90%64K	-56.01%5.8M	273.97%13.19M	--3.53M
Free cash flow	19.97%-15.7M	9.96%-19.62M	-92.13%-21.78M	-66.74%-11.34M	-47.76%-6.8M	38.92%-4.6M	-8.03%-7.53M	14.57%-6.97M	-140.69%-8.16M	---3.39M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	Unqualified Opinion	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall